Inactive

NON-COMPETITIVE COMBINED SYNOPSIS / SOLICITATION Title: Barcoded and unbarcoded 384-well and 1536-well microplates for Antiviral Program for Pandemics (APP) and Automation for the 2024 screening seaso... NON-COMPETITIVE COMBINED SYNOPSIS / SOLICITATION Title: Barcoded and unbarcoded 384-well and 1536-well microplates for Antiviral Program for Pandemics (APP) and Automation for the 2024 screening season. (i) This is a combined synopsis/solicitation for commercial items prepared in accordance with the format in Subpart 12.6 as supplemented with additional information included in this notice. This announcement constitutes the only solicitation; proposals are being requested and a written solicitation will not be issued. (ii) The solicitation number is 75N95024Q00184_CSS and the solicitation is issued as a request for quotation (RFQ). This acquisition is for a commercial item or service and is conducted under the authority of the Federal Acquisition Regulation (FAR) Part 13—Simplified Acquisition Procedures; and FAR Part 12—Acquisition of Commercial Items and is not expected to exceed the simplified acquisition threshold. THIS IS A NON-COMPETITIVE (NOTICE OF INTENT) COMBINED SYNOPSIS SOLICITATION TO AWARD A CONTRACT OR PURCHASE ORDER WITHOUT PROVIDING FOR FULL OR OPEN COMPETITION (INCLUDING BRAND-NAME). The National Institute on Drug Abuse (NIDA), Office of Acquisition (OA), on behalf of the National Center for Advancing Translational Sciences (NCATS), intends to negotiate and award a purchase order without providing for full and open competition (including brand-name) to GREINER BIO-ONE NORTH AMERICA, INC., 4238 Capital Drive, Monroe, North Carolina 28110-7681 for barcoded and unbarcoded 384-well and 1536-well microplates This acquisition is conducted as non-competitive for a commercial item or service and is conducted pursuant to FAR 13.106-1(b)(1). The rationale for the brand-name justification is that this brand of plates is currently being used to run various experiments on our HTS systems and the use of plates compatible and optimized for use with the systems are of critical importance. There are two primary factors that determine compatibility; the flange style of the plate and the support ribs underneath the plate that run along the base of the plate and connect to the outer wall. The flange of the plate must be low; the design of our robotic grippers on our screening platform is such that when it grips the plate it does so along the flange of the plate, creating a dovetail joint. This ensures that our robotic system has a solid grip and will never drop a plate. Secondly, several support ribs on the underside of the plate are removed so that they can be properly placed on pin support plate nests that are present on several of the peripheral devices on our screening systems. Without the removal of these support ribs the plates will not rest properly, and the peripheral devices will not perform correctly. Market research conducted has not identified an alternative source for these plates. (iii) The solicitation document and incorporated provisions and clauses are those in effect through Federal Acquisition Circular (FAC) Number 2022-06, with effective date May 26, 2022. (iv) The associated NAICS code is 334516 and the small business size standard 1,000 employees. This requirement is non-competitive with no set-aside restrictions. (v) This requirement is for the following items: Purchase Description: 789176-F 1536 well assay plate, black, MB 789175-F 1536 well assay plate, white, MB 789173-F 1536 well assay plate, white, TC, 60 cases total 789093-F GNF Divisions 1536W, PS, Sterile, TC Treated, WHT/CLR, w/ 2 Custom Barcodes, 10 cases 789092-F GNF Divisions 1536W, PS, Sterile, TC Treated, BLK/CLR, w/ 2 Custom Barcodes, 75 cases total 781075 384 well assay plate, white, lumitrac 781076 384 well assay plate, black, fluotrac Salient Characteristics: Dual barcode TC treated Quantity: 75 cases of 1536 well assay plate, black, MB 40 cases of 1536 well assay plate, white, MB 30 cases of 1536 well assay plate, white, TC 10 cases of GNF Divisions 1536W, PS, Sterile, TC Treated, WHT/CLR, w/ 2 Custom Barcodes 1 case of MICROPLATE, 384 WELL, PS, F-BOTTOM, BLACK, STREPTAVIDIN-COATED, 5 PCS./BAG 4 cases of CELL CULTURE MICROPLATE, 384 WELL, PS,µCLEAR®, BLACK, POLY-D-LYSINE, CELLCOAT®,lID, 5 PCS./BAG 4 cases of CELL CULTURE MICROPLATE, 384 WELL, PS, µCLEAR®, WHITE, POLY-D-LYSINE, CELLCOAT®,LID, 5 PCS./BAG" 11 cases of 384 well assay plate, white, lumitrac 9 cases of 384 well assay plate, black, fluotrac (vii) The Government anticipates award of a firm fixed-price purchase order for this acquisition, and the anticipated delivery date is thirty (30) days after receipt of order (ARO). Delivery will be f.o.b. destination. The place of delivery and acceptance will be 9800 Medical Center Drive, Rockville, MD 20850. (viii) The additional instructions to offerors are as follows: The provision at FAR 52.252-1, Solicitation Provisions Incorporated by Reference (Feb 1998), applies to this acquisition. This solicitation incorporates one or more solicitation provisions by reference, with the same force and effect as if they were given in full text. Upon request, the Contracting Officer will make their full text available. The offeror is cautioned that the listed provisions may include blocks that must be completed by the offeror and submitted with its quotation or offer. In lieu of submitting the full text of those provisions, the offeror may identify the provision by paragraph identifier and provide the appropriate information with its quotation or offer. Also, the full text of a solicitation provision may be accessed electronically at these addresses: https://www.acquisition.gov/browse/index/far https://www.hhs.gov/grants/contracts/contract-policies-regulations/hhsar/index.html (End of provision) The following provisions apply to this acquisition and are incorporated by reference: FAR 52.204-7, System for Award Management (Oct 2018) FAR 52.204-16, Commercial and Government Entity Code Reporting (Aug 2020) FAR 52.212-1, Instructions to Offerors-Commercial Items (Nov 2021) FAR 52.212-3, Offeror Representations and Certifications-Commercial Items (Nov 2021) FAR 52.225-2, Buy American Certificate (Feb 2021) HHSAR 352.239-73, Electronic and Information Technology Accessibility Notice (December 18, 2015) The clause at FAR 52.252-2, Clauses Incorporated by Reference (Feb 1998), applies to this acquisition. This contract incorporates one or more clauses by reference, with the same force and effect as if they were given in full text. Upon request, the Contracting Officer will make their full text available. Also, the full text of a clause may be accessed electronically at these addresses: https://www.acquisition.gov/browse/index/far https://www.hhs.gov/grants/contracts/contract-policies-regulations/hhsar/index.html (End of clause) The following clauses apply to this acquisition and are incorporated by reference: FAR 52.204-13, System for Award Management Maintenance (Oct 2018) FAR 52.204-18, Commercial and Government Entity Code Maintenance (Aug 2020) FAR 52.212-4, Contract Terms and Conditions-Commercial Items (Nov 2021). Addendum to this FAR clause applies to this acquisition and is attached. HHSAR 352.239-74, Electronic and Information Technology Accessibility (December 18, 2015) The following provisions and clauses apply to this acquisition and are attached in full text. Offerors MUST complete the provisions at 52.204-24 and 52.204-26 and submit completed copies as separate documents with their proposal. FAR 52.204-24 Representation Regarding Certain Telecommunications and Video Surveillance Services or Equipment (Nov 2021) FAR 52.204-26 Covered Telecommunications Equipment or Services-Representation (Oct 2020) FAR 52.212-5, Contract Terms and Conditions Required to Implement Statutes or Executive Orders-Commercial Items (Jan 2022) FAR 52.225-2 Buy American Certificate (Feb 2021) NIH Invoice and Payment Provisions (Feb 2021) (ix) The Government will evaluate quotations or offers in accordance with FAR 13.106-2 and award a purchase order from this solicitation to the responsible offeror whose quote conforming to the solicitation will be most advantageous to the Government, price and other factors considered. The following factors shall be used to evaluate quotes: a. Technical capability of the item offered to meet the Government requirement; and b. Price (x) The Offerors to include a completed copy of the provision at FAR clause 52.212-3, Offeror Representations and Certifications-Commercial Items (Nov 2021), with its offer. If the offeror has completed FAR clause 52.212-3 at www.sam.gov, then the offeror does not need to provide a completed copy with its offer. (xi) The clause at FAR 52.212-4, Contract Terms and Conditions-Commercial Items (Nov 2021), applies to this acquisition. Addendum to this FAR clause applies to this acquisition and is attached. (xii) There are no additional contract requirement(s) or terms and conditions applicable to this acquisition. (xiii) The Defense Priorities and Allocations System (DPAS) are not applicable to this requirement. HS reserves the right to exercise priorities and allocations authority with respect to this contract, to include rating this order in accordance with 45 CFR Part 101, Subpart A—Health Resources Priorities and Allocations System.” (xiv) Responses to this solicitation must include sufficient information to establish the interested parties’ bona-fide capabilities of providing the product or service. The price quote shall include: unit price, list price, shipping and handling costs, delivery days after contract award, delivery terms, prompt payment discount terms, F.O.B. Point (Destination or Origin), product or catalog number(s), product description, and any other information or factors that may be considered in the award decision. Such factors may include: past performance, special features required for effective program performance, trade-in considerations, probable life of the item selected as compared with that of a comparable item, warranty considerations, maintenance availability, and environmental and energy efficiency considerations. Respondents that believe that they are manufacturers or authorized resellers of the brand-name product specified in this announcement must provide, as part of their response: (a) product, catalog, model, and/or part number(s); (b) product description; (c) all relevant information and documentation that the item(s) offered meets the salient physical, functional, or performance characteristics as specified in the purchase description; quantity; estimated price or cost; shipping, handling, and/or installation charges; and delivery date after receipt of order. The Unique Entity ID from SAM.gov, the Taxpayer Identification Number (TIN), and the certification of business size must be included in the response. All offerors must have an active registration in the System for Award Management (SAM) www.sam.gov. All questions must be received by 11:00 a.m., Eastern Standard Time, on April 22, 2024 and reference Solicitation Number 75N95024Q00184_CSS. Responses must be submitted electronically to Nick Niefeld, Contract Specialist, at nick.niefeld@nih.gov. All quotations must be received by 11:00 a.m., Eastern Standard Time, on April 26, 2024 and reference Solicitation Number 75N95024Q00184_CSS. Responses must be submitted electronically to Nick Niefeld, Contract Specialist, at nick.niefeld@nih.gov. Fax responses will not be accepted.

Inactive

SAM.gov SOURCES SOUGHT NOTICE Solicitation Number: 75N95024Q00184 Title: Barcoded and unbarcoded 384-well and 1536-well microplates Classification Code: 6640 NAICS Code: 334516-Analytical Laboratory I... SAM.gov SOURCES SOUGHT NOTICE Solicitation Number: 75N95024Q00184 Title: Barcoded and unbarcoded 384-well and 1536-well microplates Classification Code: 6640 NAICS Code: 334516-Analytical Laboratory Instrument Manufacturing Size Standard: 1,000 employees Description: This is a Sources Sought notice. This is NOT a solicitation for proposals, proposal abstracts, or quotations. The purpose of this notice is to obtain information regarding the availability and capability of all qualified sources to perform a potential requirement. This notice is issued to help determine the availability of qualified companies technically capable of meeting the Government requirement, to determine the method of acquisition, and availability of domestic sources manufactured in the United States in sufficient and reasonably available commercial quantities and of a satisfactory quality. It is not to be construed as a commitment by the Government to issue a solicitation or ultimately award a contract. Responses will not be considered as proposals or quotes. No award will be made as a result of this notice. The Government will NOT be responsible for any costs incurred by the respondents to this notice. This notice is strictly for research and information purposes only. Small businesses are encouraged to respond. For equipment/supply requirements, responses must include the place of manufacturing (i.e., address if supply/equipment is a domestic end product and include country of manufacture). For equipment/supply requirements, small businesses must also address the size status of the manufacturer under the applicable NAICS code (i.e., address Non-Manufacturer Rule). Background: The National Center for Advancing Translational Sciences (NCATS) is a part of the National Institutes of Health (NIH), which mission it is to catalyze the generation of innovative methods and technologies that will enhance the development, testing and implementation of diagnostics and therapeutics across a wide range of human diseases and conditions. The Antiviral Program for Pandemics (APP) aims to develop safe and effective antivirals to combat SARS-CoV-2. APP will accelerate the development of a portfolio of promising antivirals that can quickly pivot to combat future pandemics. Having safe and effective oral antiviral candidates ready for deployment in later-stage clinical trials against a newly emergent virus would save lives, reduce serious illness and prevent overwhelming surges in hospitalizations during a viral outbreak or pandemic. The APP and other biology groups as needed are in full swing ramping up into their screening season on the robotic systems and as a result will need of various 384-well and 1536-well microplates in order to perform their scheduled assay screens and combination matrix studies for a vast quantity of projects. The particular plates are available through Greiner-Bio who has provided us with a customized quote specifically for NCATS Purpose and Objectives: The purpose of this notice is to identify potential sources for the acquisition of barcoded and unbarcoded 384-well and 1536-well microplates for APP and Automation and other biology groups as needed to supply them for the 2024 screening season. Generic Name of Product: 1536-well and 384-well Microplates for Automated Combination Matrix Screening Purchase Description: 789176-F 1536 well assay plate, black, MB 789175-F 1536 well assay plate, white, MB 789173-F 1536 well assay plate, white, TC 789093-F GNF Divisions 1536W, PS, Sterile, TC Treated, WHT/CLR, w/ 2 Custom Barcodes 781997 MICROPLATE, 384 WELL, PS, F-BOTTOM, BLACK, STREPTAVIDIN-COATED, 5 PCS./BAG 781946 CELL CULTURE MICROPLATE, 384 WELL, PS,µCLEAR®, BLACK, POLY-D-LYSINE, CELLCOAT®,lID, 5 PCS./BAG 781944 CELL CULTURE MICROPLATE, 384 WELL, PS, µCLEAR®, WHITE, POLY-D-LYSINE, CELLCOAT®,LID, 5 PCS./BAG" 781075 384 well assay plate, white, lumitrac 781076 384 well assay plate, black, fluotrac Salient characteristics Dual barcode TC treated Quantity: 75 cases of 1536 well assay plate, black, MB 40 cases of 1536 well assay plate, white, MB 30 cases of 1536 well assay plate, white, TC 10 cases of GNF Divisions 1536W, PS, Sterile, TC Treated, WHT/CLR, w/ 2 Custom Barcodes 1 case of MICROPLATE, 384 WELL, PS, F-BOTTOM, BLACK, STREPTAVIDIN-COATED, 5 PCS./BAG 4 cases of CELL CULTURE MICROPLATE, 384 WELL, PS,µCLEAR®, BLACK, POLY-D-LYSINE, CELLCOAT®,lID, 5 PCS./BAG 4 cases of CELL CULTURE MICROPLATE, 384 WELL, PS, µCLEAR®, WHITE, POLY-D-LYSINE, CELLCOAT®,LID, 5 PCS./BAG" 11 cases of 384 well assay plate, white, lumitrac 9 cases of 384 well assay plate, black, fluotrac Anticipated period of performance: 30 days after receipt of award Other important considerations: In case domestic sources are available and capable of fulfilling the Government’s need, and a future solicitation is published, the Government will use evaluation preferences in accordance with FAR 25. Capability statement /information sought. Companies that believe they possess the capabilities to provide the required products should submit documentation of their ability to meet each of the project requirements to the Contracting Officer. The capability statement must specifically address each of the project requirements separately. Additionally, the capability statement should include 1) the total number of employees, 2) the professional qualifications of personnel as it relates to the requirements outlined, 3) any contractor GSA Schedule contracts and/or other government-wide acquisition contracts (GWACs) by which all of the requirements may be met, if applicable, and 4) any other information considered relevant to this program. Capability statements must also include the Company Name, Unique Entity ID from SAM.gov, Physical Address, and Point of Contact Information. The response must include the respondents’ technical and administrative points of contact, including names, titles, addresses, telephone and fax numbers, and e-mail addresses. Interested companies are required to identify their type of business, applicable North American Industry Classification System (NAICS) Code, and size standards in accordance with the Small Business Administration. The government requests that no proprietary or confidential business data be submitted in a response to this notice. However, responses that indicate the information therein is proprietary will be properly safeguarded for Government use only. Capability statements must include the name and telephone number of a point of contact having authority and knowledge to discuss responses with Government representatives. Capability statements in response to this market survey that do not provide sufficient information for evaluation will be considered non-responsive. When submitting this information, please reference the solicitation notice number. One (1) copy of the response is required and must be in Microsoft Word or Adobe PDF format using 11-point or 12-point font, 8-1/2” x 11” paper size, with 1” top, bottom, left and right margins, and with single or double spacing. The information submitted must be in and outline format that addresses each of the elements of the project requirement and in the capability statement /information sought paragraphs stated herein. A cover page and an executive summary may be included but is not required. The response is limited to ten (10) page limit. The 10-page limit does not include the cover page, executive summary, or references, if requested. All responses to this notice must be submitted electronically to the Contract Specialist and Contracting Officer. Facsimile responses are NOT accepted. The response must be submitted to Nick Niefeld at nick.niefeld@nih.gov. The response must be received on or before March 14, 2024, 10:00 AM Eastern Time. Disclaimer and Important Notes: This notice does not obligate the Government to award a contract or otherwise pay for the information provided in response. The Government reserves the right to use information provided by respondents for any purpose deemed necessary and legally appropriate. Any organization responding to this notice should ensure that its response is complete and sufficiently detailed to allow the Government to determine the organization’s qualifications to perform the work. Respondents are advised that the Government is under no obligation to acknowledge receipt of the information received or provide feedback to respondents with respect to any information submitted. After a review of the responses received, a presolicitation synopsis and solicitation may be published in www.sam.gov. However, responses to this notice will not be considered adequate responses to a solicitation. Confidentiality: No proprietary, classified, confidential, or sensitive information should be included in your response. The Government reserves the right to use any non-proprietary technical information in any resultant solicitation(s).